Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Prevalence of muscle injury following intra-arterial chemotherapy

Prevalence of muscle injury following intra-arterial chemotherapy  Objective. Intra-arterial chemotherapy (IAC) is frequently used as an adjuvant treatment for musculoskeletal tumors. Past studies have noted that IAC not only induces favorable effects in tumor, but may also cause muscle edema and necrosis in previously normal tissue, reflected as increased signal on T2-weighted scans. In order to evaluate the prevalence of these effects, we reviewed all patients receiving IAC and MRI at our institution. Methods. Our study population consisted of 24 patients who underwent IAC. All subjects were studied with MRI both pre-and post-IAC. None of the subjects in this study underwent surgery or radiation therapy until after the post-IAC MRI examination. Any muscle group involved by the tumor or peritumoral edema on the initial scan was excluded from the study. Catheter position during IAC was recorded as central or peripheral. Scans were scored positive if muscle groups in regions remote from the tumor site demonstrated increased T2 signal following IAC. Results. Six out of these 24 patients (25%) were found to have positive results. A significant association was found between peripheral catheter position and a positive scan post-IAC (Fisher’s exact test, P=0.024). Conclusion. Because of our exclusion criteria, we are convinced that the finding of increased T2 signal in 25% of our patients was caused by IAC and represents muscle edema or necrosis. Knowledge of this post-chemotherapy MR finding should help prevent confusion during the interpretation of follow-up MR examinations. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Skeletal Radiology Springer Journals

Prevalence of muscle injury following intra-arterial chemotherapy

Download PDF
4 pages

Loading next page...
 
/lp/springer-journals/prevalence-of-muscle-injury-following-intra-arterial-chemotherapy-HU5Qo7WopY

References (15)

Publisher
Springer Journals
Copyright
Copyright © 1996 by International Skeletal Society
Subject
Medicine & Public Health; Imaging / Radiology; Orthopedics; Pathology; Nuclear Medicine
ISSN
0364-2348
eISSN
1432-2161
DOI
10.1007/s002560050093
Publisher site
See Article on Publisher Site

Abstract

 Objective. Intra-arterial chemotherapy (IAC) is frequently used as an adjuvant treatment for musculoskeletal tumors. Past studies have noted that IAC not only induces favorable effects in tumor, but may also cause muscle edema and necrosis in previously normal tissue, reflected as increased signal on T2-weighted scans. In order to evaluate the prevalence of these effects, we reviewed all patients receiving IAC and MRI at our institution. Methods. Our study population consisted of 24 patients who underwent IAC. All subjects were studied with MRI both pre-and post-IAC. None of the subjects in this study underwent surgery or radiation therapy until after the post-IAC MRI examination. Any muscle group involved by the tumor or peritumoral edema on the initial scan was excluded from the study. Catheter position during IAC was recorded as central or peripheral. Scans were scored positive if muscle groups in regions remote from the tumor site demonstrated increased T2 signal following IAC. Results. Six out of these 24 patients (25%) were found to have positive results. A significant association was found between peripheral catheter position and a positive scan post-IAC (Fisher’s exact test, P=0.024). Conclusion. Because of our exclusion criteria, we are convinced that the finding of increased T2 signal in 25% of our patients was caused by IAC and represents muscle edema or necrosis. Knowledge of this post-chemotherapy MR finding should help prevent confusion during the interpretation of follow-up MR examinations.

Journal

Skeletal Radiology – Springer Journals

Published: May 6, 1996

There are no references for this article.